David A. Sallman. To target the untargetable: elucidation of synergy of APR-246 and azacitidine in TP53 mutant myelodysplastic syndromes and acute myeloid leukemia. Haematologica 2020; 105(6):1470-1472; https://doi.org/10.3324/haematol.2020.249060.